All citations were evaluated for relevant content and validation.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Stereotactic ablative body radiotherapy (SABR) allows the administration of ablative doses of radiation in a focused form with a low probability of side effects and is widely used for cancer treatment.
📊
Key Findings & Data:In this review, we analyzed published literature on PubMed and MEDLINE with papers published in the past 5 years.
💡
Conclusion & Impact:All citations were evaluated for relevant content and validation.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Özet
Stereotactic ablative body radiotherapy (SABR) allows the administration of ablative doses of radiation in a focused form with a low probability of side effects and is widely used for cancer treatment. However, in the recent years its usefulness in benign cardiac pathology is being studied. In this study, we aimed to guide the cardiologist in SABR and its applications in treatment of refractory ventricular tachycardia. In this review, we analyzed published literature on PubMed and MEDLINE with papers published in the past 5 years. We included papers in the English language with information about indications, radiotherapy plan, doses and fractionations, and outcomes. All citations were evaluated for relevant content and validation.
🔖
Cite This Article
PİNTA, C. D. L., BESSE, R. (2021). Stereotactic ablative body radiotherapy for ventricular tachycardia: An alternative therapy for refractory patients. The Anatolian Journal of Cardiology, Cilt: 25 - Sayı: 12, 858–862. https://ajindex.com/articles/365127
[Article in English, Spanish] [Crossref] 2. Yokokawa M, Desjardins B, Crawford T, Good E, Morady F, Bogun F. Reasons for recurrent ventricular tachycardia after catheter ablation of post-infarction ventricular tachycardia. J Am Coll Cardiol 2013
[Crossref] 3. Kumar S, Barbhaiya CR, Sobieszczyk P, Eisenhauer AC, Couper GS, Nagashima K, et al. Role of alternative interventional procedures when endo- and epicardial catheter ablation attempts for ventricular arrhythmias fail. Circ Arrhythm Electrophysiol 2015
[Crossref] 4. Blanck O, Buergy D, Vens M, Eidinger L, Zaman A, Krug D, et al. Radiosurgery for ventricular tachycardia: preclinical and clinical evidence and study design for a German multi-center multi-platform feasibility trial (RAVENTA). Clin Res Cardiol 2020
[Crossref] 5. Jumeau R, Ozsahin M, Schwitter J, Vallet V, Duclos F, Zeverino M, et al. Rescue procedure for an electrical storm using robotic non-invasive cardiac radio-ablation. Radiother Oncol 2018
[Crossref] 6. van der Ree MH, Blanck O, Limpens J, Lee CH, Balgobind BV, Dieleman EMT, et al. Cardiac radioablation- A systematic review. Heart Rhythm 2020
[Crossref] 7. Jumeau R, Ozsahin M, Schwitter J, Elicin O, Reichlin T, Roten L, et al. Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions. Front Cardiovasc Med 2020
[Crossref] 8. Loo BW Jr, Soltys SG, Wang L, Lo A, Fahimian BP, Iagaru A, et al. Stereotactic ablative radiotherapy for the treatment of refractory cardiac ventricular arrhythmia. Circ Arrhythm Electrophysiol 2015
[Crossref] 9. Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M, et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Europace 2019
[Crossref] 10. Lloyd MS, Wight J, Schneider F, Hoskins M, Attia T, Escott C, et al. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm 2020
[Crossref] 11. Cuculich PS, Schill MR, Kashani R, Mutic S, Lang A, Cooper D, et al. Noninvasive Cardiac Radiation for Ablation of Ventricular Tachycardia. N Engl J Med 2017
[Crossref] 12. Robinson CG, Samson P, Moore KMS, Hugo GD, Knutson N, Mutic S. et al. Longer term results from a